Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (6): 603-606.DOI: 10.3969/j.issn.1673-8640.2023.06.019
Received:2022-04-21
Revised:2022-12-08
Online:2023-06-30
Published:2023-08-22
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.06.019
| 检测时间 | 年龄 | 身高/cm | 查体 | 促卵泡激素/ （mIU/mL） | 黄体生成素 / （mIU/mL） | 雌二醇/ （pg/mL） |
|---|---|---|---|---|---|---|
| 2020年3月27日 | 11岁4个月 | 138 | 乳房B2期，阴毛PH2期 | 0.55 | <0.09 | <10.00 |
| 2021年1月8日 | 12岁2个月 | 142 | 乳房B2期，阴毛PH2期 | 0.47 | 0.13 | <10.00 |
| 2021年7月18日（戴泵前） | 12岁7个月 | 145 | 乳房B2期，阴毛PH2期 | 0.09 | <0.09 | <10.00 |
| 2021年8月24日（戴泵1个月） | 12岁8个月 | 146 | 乳房B2期，阴毛PH2期 | 0.11 | 2.20 | <10.00 |
| 检测时间 | 年龄 | 身高/cm | 查体 | 促卵泡激素/ （mIU/mL） | 黄体生成素 / （mIU/mL） | 雌二醇/ （pg/mL） |
|---|---|---|---|---|---|---|
| 2020年3月27日 | 11岁4个月 | 138 | 乳房B2期，阴毛PH2期 | 0.55 | <0.09 | <10.00 |
| 2021年1月8日 | 12岁2个月 | 142 | 乳房B2期，阴毛PH2期 | 0.47 | 0.13 | <10.00 |
| 2021年7月18日（戴泵前） | 12岁7个月 | 145 | 乳房B2期，阴毛PH2期 | 0.09 | <0.09 | <10.00 |
| 2021年8月24日（戴泵1个月） | 12岁8个月 | 146 | 乳房B2期，阴毛PH2期 | 0.11 | 2.20 | <10.00 |
| 项目 | 2021年1月15日 | 2021年7月29日（试戴泵6 d） | |||
|---|---|---|---|---|---|
| 促卵泡激素/（mIU/mL） | 黄体生成素/（mIU/mL） | 促卵泡激素/（mIU/mL） | 黄体生成素/（mIU/mL） | ||
| 0 min | 0.1 | <0.09 | 1.89 | 1.68 | |
| 30 min | 1.33 | 0.62 | 2.78 | 2.12 | |
| 60 min | 1.79 | 0.70 | 2.44 | 1.59 | |
| 90 min | 1.96 | 0.62 | 2.35 | 1.14 | |
| 120 min | 2.19 | 0.64 | 2.80 | 1.16 | |
| 黄体生成素峰值/促卵泡激素峰值 | 0.32 | 0.76 | |||
| 项目 | 2021年1月15日 | 2021年7月29日（试戴泵6 d） | |||
|---|---|---|---|---|---|
| 促卵泡激素/（mIU/mL） | 黄体生成素/（mIU/mL） | 促卵泡激素/（mIU/mL） | 黄体生成素/（mIU/mL） | ||
| 0 min | 0.1 | <0.09 | 1.89 | 1.68 | |
| 30 min | 1.33 | 0.62 | 2.78 | 2.12 | |
| 60 min | 1.79 | 0.70 | 2.44 | 1.59 | |
| 90 min | 1.96 | 0.62 | 2.35 | 1.14 | |
| 120 min | 2.19 | 0.64 | 2.80 | 1.16 | |
| 黄体生成素峰值/促卵泡激素峰值 | 0.32 | 0.76 | |||
| [1] |
WHITLOCK K E. Origin and development of GnRH neurons[J]. Trends Endocrinol Metab, 2005, 16(4):145-151.
DOI URL |
| [2] | 王秋菊, 沈亦平, 陈少科, 等. 遗传变异分类标准与指南[J]. 中国科学(生命科学), 2017, 47(6):668-688. |
| [3] | 中华医学会儿科学分会内分泌遗传代谢学组, 中华儿科杂志编辑委员会. 中枢性性早熟诊断与治疗专家共识(2022)[J]. 中华儿科杂志, 2023, 61(1):16-22. |
| [4] |
ZHAO Y, YANG F, QIU L, et al. A novel heterozygous intron mutation in SEMA7A causing kallmann syndrome in a female[J]. Gynecol Endocrinol, 2020, 36(3):218-221.
DOI PMID |
| [5] |
HARDELIN J P, DODÉ C. The complex genetics of Kallmann syndrome:KAL1,FGFR1,FGF8,PROKR2,PROK2,et al[J]. Sex Dev, 2008, 2(4-5):181-193.
DOI URL |
| [6] | 陈娇, 袁珂, 何敏菲, 等. 5例Kallmann综合征患者的临床及遗传学分析[J]. 中国当代儿科杂志, 2018, 20(11):925-929. |
| [7] |
BIANCO S D, KAISER U B. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism[J]. Nat Rev Endocrinol, 2009, 5(10):569-576.
DOI PMID |
| [8] | 唐瑞怡, 马淼. 女性特发性低促性腺激素性性腺功能减退症诊疗新进展[J]. 现代妇产科进展, 2018, 27(12):942-944. |
| [9] | 中华医学会内分泌学分会性腺学组. 特发性低促性腺激素性性腺功能减退症诊治专家共识[J]. 中华内科杂志, 2015, 54(8):739-744. |
| [10] | 中华医学会男科学分会, 下丘脑促性腺激素释放激素脉冲泵在男科疾病中应用专家共识编写组. 下丘脑促性腺激素释放激素脉冲泵在男科疾病中应用专家共识[J]. 中华男科学杂志, 2022, 28(3):273-280. |
| [11] | BOEHM U, BOULOUX P M, DATTANI M T, et al. Expert consensus document:European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis,diagnosis and treatment[J]. Nat Rev Endocrinol, 2015, 11(9):547-564. |
| [12] |
FU C P, LEE I T. Kallmann syndrome with micropenis[J]. Am J Med Sci, 2018, 356(2):e23.
DOI URL |
| [13] | 岳志领, 杨素君, 相世峰, 等. Kallmann综合征的临床特点及MRI表现[J]. 医学影像学杂志, 2020, 30(5):859-862. |
| [14] |
AU M G, CROWLEY W F Jr, BUCK C L. Genetic counseling for isolated GnRH deficiency[J]. Mol Cell Endocrinol, 2011, 346(1-2):102-109.
DOI PMID |
| [15] | 王怡, 邓晶鑫, 胡梅新, 等. CHD7基因新发变异引起的CHARGE综合征1例 [J/CD]. 中国临床案例成果数据库, 2022, 4(1):E02362. |
| [16] |
THOMAS A T, WAITE J, WILLIAMS C A, et al. Phenotypic characteristics and variability in CHARGE syndrome:a PRISMA compliant systematic review and meta-analysis[J]. J Neurodev Disord, 2022, 14(1):49.
DOI |
| [17] |
BALASUBRAMANIAN R, CROWLEY W F Jr. Reproductive endocrine phenotypes relating to CHD7 mutations in humans[J]. Am J Med Genet C Semin Med Genet, 2017, 175(4):507-515.
DOI URL |
| [18] |
MEISNER J K, MARTIN D M. Congenital heart defects in CHARGE:the molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes[J]. Am J Med Genet C Semin Med Genet, 2020, 184(1):81-89.
DOI URL |
| [19] |
TRIDER C L, ARRA-ROBAR A, VAN RAVENSWAAIJ-ARTS C, et al. Developing a CHARGE syndrome checklist:health supervision across the lifespan(from head to toe)[J]. Am J Med Genet A, 2017, 173(3):684-691.
DOI URL |
| [20] |
YOUNG J, XU C, PAPADAKIS G E, et al. Clinical management of congenital hypogonadotropic hypogonadism[J]. Endocr Rev, 2019, 40(2):669-710.
DOI PMID |
| [21] |
WEI C, LONG G, ZHANG Y, et al. Spermatogenesis of male patients with congenital hypogonadotropic hypogonadism receiving pulsatile gonadotropin-releasing hormone therapy versus gonadotropin therapy:a systematic review and meta-analysis[J]. World J Mens Health, 2021, 39(4):654-665.
DOI URL |
| [22] |
GONG C, LIU Y, QIN M, et al. Pulsatile GnRH is superior to hCG in therapeutic efficacy in adolescent boys with hypogonadotropic hypogonadodism[J]. J Clin Endocrinol Metab, 2015, 100(7):2793-2799.
DOI PMID |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
